Chemical & Toxic Substances
Documents
112-TCA OECD428 Dermal Final Study Report EPA Technical Review Memo
0 comments
Analysis in progress
Top issues in comments
1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-Hexamethylcyclopenta [g]-2-Benzopyran (HHCB) and Phthalic Anhydride Draft Risk Evaluations Under the Toxic Substances Control Act (TSCA); Notice of Availability and Request for Comment
0 comments
Net support +8% across analyzed comments
Top issues in comments
- Drinking water treatment
- Equivalent measures
- Failure to evaluate all conditions of use
1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-Hexamethylcyclopenta [g]-2-Benzopyran (HHCB) and Phthalic Anhydride Draft Risk Evaluations Under the Toxic Substances Control Act (TSCA); Notice of Availability and Request for Comment
0 comments
Net support +13% across analyzed comments
Top issues in comments
- Product use and risk
- De minimis threshold
- Occupational exposure assessment
4,4′-(1-Methylethylidene)bis[2,6-dibromophenol] (TBBPA) Risk Evaluation Under the Toxic Substances Control Act (TSCA); Notice of Availability and Request for Comment
0 comments
Analysis in progress
Top issues in comments
01. Draft Risk Evaluation for TBBPA
0 comments
Analysis in progress
Top issues in comments
02. Draft Physical Chemistry and Fate Assessment for TBBPA
0 comments
Analysis in progress
Top issues in comments
03. Draft Release Assessment for TBBPA
0 comments
Analysis in progress
Top issues in comments
04. Draft Occupational Exposure Assessment for TBBPA
0 comments
Analysis in progress
Top issues in comments
05. Draft Consumer and Indoor Dust Exposure Assessment for TBBPA
0 comments
Analysis in progress
Top issues in comments
06. Draft Environmental Media, General Population Exposure, and Environmental Exposure Assessment for TBBPA
0 comments
Analysis in progress
Top issues in comments
07. Draft Human Health and Environmental Hazard Assessment for TBBPA
0 comments
Analysis in progress
Top issues in comments
08. Draft Systematic Review Protocol for TBBPA
0 comments
Analysis in progress
Top issues in comments
